Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

The cannabinoid 1 (CB(1)) receptor antagonist rimonabant (SR141716) alters rewarding properties and intake of food and drugs. Additionally, striatal dopamine D2 receptor (DRD2) availability has been implicated in reward function. This study shows that chronic treatment of rats with rimonabant (1.0 a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Crunelle, Cleo L., van de Giessen, Elsmarieke, Schulz, Sybille, Vanderschuren, Louk J.M.J., de Bruin, Kora, van den Brink, Wim, Booij, Jan
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3252421/
https://ncbi.nlm.nih.gov/pubmed/21955259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1369-1600.2011.00369.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi